Skip to main content
Top
Published in: Endocrine 1/2020

01-04-2020 | Hypokalemia | Original Article

Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3

Authors: Yue Han, Hai Cheng, Shihong Shao, Yanhua Lang, Xiangzhong Zhao, Yi Lin, Sai Wang, Xiaomeng Shi, Zhiying Liu, Leping Shao

Published in: Endocrine | Issue 1/2020

Login to get access

Abstract

Purpose

Analyze the genotype of 42 Chinese patients with Bartter syndrome type 3 (BS3) and investigate their correlation between genotype and phenotype.

Methods

Identify CLCNKB gene variants by the next-generation sequencing and the multiplex ligation-dependent probe amplification (MLPA), and then evaluate their mutation effects according to 2015 American College of Medical Genetics and Genomics (ACMG) standards and guidelines.

Results

Thirty-six different variants in CLCNKB gene, including 13 novel ones, were found. The whole gene deletion of CLCNKB gene was the most frequent mutation (40%), and the rate of large deletions is up to 55%. Among 36 variants, six (c.1244T>A, c.1468G>A, c.849_851delCTT, c.359G>T, c.1052G>T, and c.1309G>A) and three (c.228A>C, c.1294_1295TA>CT, and c.1333T>G) variants were classified as “likely pathogenic variants” and “variants with uncertain significance (VUS),” respectively. The other 27 variants were classified as “pathogenic variants”. The most common symptoms included: growth retardation (38/42), polydipsia and polyuria (35/42), constipation (31/42), and vomiting (27/42). All patients presented with hypokalemia, hypochloremia, and metabolic alkalosis. The genotype and phenotype association study revealed that who had mutations probably resulting in complete loss of function of both alleles might have severer phenotype. After the treatment that based on indomethacin and potassium chloride, most patients could achieve obvious recovery of growth rate and restoration of hypokalemia.

Conclusions

The present study have found 36 variants of CLCNKB gene, including 13 novel ones, which enrich the human gene mutation database and provide valuable references to diagnosis, treatment, and the genetic counseling of Chinese population.
Literature
1.
go back to reference S.C. Hebert, Bartter syndrome. Curr. Opin. Nephrol. Hypertens. 12(5), 527–532 (2003)CrossRef S.C. Hebert, Bartter syndrome. Curr. Opin. Nephrol. Hypertens. 12(5), 527–532 (2003)CrossRef
2.
go back to reference T.D.S. Cunha, I.P. Heilberg, Bartter syndrome: causes, diagnosis, and treatment. Int. J. Nephrol. Renovasc. Dis. 11, 291–301 (2018)CrossRef T.D.S. Cunha, I.P. Heilberg, Bartter syndrome: causes, diagnosis, and treatment. Int. J. Nephrol. Renovasc. Dis. 11, 291–301 (2018)CrossRef
3.
go back to reference K. Brochard, O. Boyer, A. Blanchard, C. Loirat, P. Niaudet, M.A. Macher, G. Deschenes, A. Bensman, S. Decramer, P. Cochat, D. Morin, F. Broux, M. Caillez, C. Guyot, R. Novo, X. Jeunemaitre, R. Vargas-Poussou, Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol. Dial. Transplant. 24(5), 1455–1464 (2009)CrossRef K. Brochard, O. Boyer, A. Blanchard, C. Loirat, P. Niaudet, M.A. Macher, G. Deschenes, A. Bensman, S. Decramer, P. Cochat, D. Morin, F. Broux, M. Caillez, C. Guyot, R. Novo, X. Jeunemaitre, R. Vargas-Poussou, Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol. Dial. Transplant. 24(5), 1455–1464 (2009)CrossRef
4.
go back to reference K. Laghmani, B.B. Beck, S.S. Yang, E. Seaayfan, A. Wenzel, B. Reusch, H. Vitzthum, D. Priem, S. Demaretz, K. Bergmann, L.K. Duin, H. Gobel, C. Mache, H. Thiele, M.P. Bartram, C. Dombret, J. Altmuller, P. Nurnberg, T. Benzing, E. Levtchenko, H.W. Seyberth, G. Klaus, G. Yigit, S.H. Lin, A. Timmer, T.J. de Koning, S.A. Scherjon, K.P. Schlingmann, M.J. Bertrand, M.M. Rinschen, Ode Backer, M. Konrad, M. Komhoff, Polyhydramnios, transient antenatal Bartter’s syndrome, and MAGED2 mutations. N. Engl. J. Med. 374(19), 1853–1863 (2016)CrossRef K. Laghmani, B.B. Beck, S.S. Yang, E. Seaayfan, A. Wenzel, B. Reusch, H. Vitzthum, D. Priem, S. Demaretz, K. Bergmann, L.K. Duin, H. Gobel, C. Mache, H. Thiele, M.P. Bartram, C. Dombret, J. Altmuller, P. Nurnberg, T. Benzing, E. Levtchenko, H.W. Seyberth, G. Klaus, G. Yigit, S.H. Lin, A. Timmer, T.J. de Koning, S.A. Scherjon, K.P. Schlingmann, M.J. Bertrand, M.M. Rinschen, Ode Backer, M. Konrad, M. Komhoff, Polyhydramnios, transient antenatal Bartter’s syndrome, and MAGED2 mutations. N. Engl. J. Med. 374(19), 1853–1863 (2016)CrossRef
5.
go back to reference R. Vargas-Poussou, C. Huang, P. Hulin, P. Houillier, X. Jeunemaitre, M. Paillard, G. Planelles, M. Dechaux, R.T. Miller, C. Antignac, Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13(9), 2259–2266 (2002)CrossRef R. Vargas-Poussou, C. Huang, P. Hulin, P. Houillier, X. Jeunemaitre, M. Paillard, G. Planelles, M. Dechaux, R.T. Miller, C. Antignac, Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13(9), 2259–2266 (2002)CrossRef
6.
go back to reference E. Seys, O. Andrini, M. Keck, L. Mansour-Hendili, P.Y. Courand, C. Simian, G. Deschenes, T. Kwon, A. Bertholet-Thomas, G. Bobrie, J.S. Borde, G. Bourdat-Michel, S. Decramer, M. Cailliez, P. Krug, P. Cozette, J.D. Delbet, L. Dubourg, D. Chaveau, M. Fila, N. Jourde-Chiche, B. Knebelmann, M.P. Lavocat, S. Lemoine, D. Djeddi, B. Llanas, F. Louillet, E. Merieau, M. Mileva, L. Mota-Vieira, C. Mousson, F. Nobili, R. Novo, G. Roussey-Kesler, I. Vrillon, S.B. Walsh, J. Teulon, A. Blanchard, R. Vargas-Poussou, Clinical and genetic spectrum of Bartter syndrome type 3. J. Am. Soc. Nephrol. 28(8), 2540–2552 (2017)CrossRef E. Seys, O. Andrini, M. Keck, L. Mansour-Hendili, P.Y. Courand, C. Simian, G. Deschenes, T. Kwon, A. Bertholet-Thomas, G. Bobrie, J.S. Borde, G. Bourdat-Michel, S. Decramer, M. Cailliez, P. Krug, P. Cozette, J.D. Delbet, L. Dubourg, D. Chaveau, M. Fila, N. Jourde-Chiche, B. Knebelmann, M.P. Lavocat, S. Lemoine, D. Djeddi, B. Llanas, F. Louillet, E. Merieau, M. Mileva, L. Mota-Vieira, C. Mousson, F. Nobili, R. Novo, G. Roussey-Kesler, I. Vrillon, S.B. Walsh, J. Teulon, A. Blanchard, R. Vargas-Poussou, Clinical and genetic spectrum of Bartter syndrome type 3. J. Am. Soc. Nephrol. 28(8), 2540–2552 (2017)CrossRef
7.
go back to reference J.W. Lee, J. Lee, Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome. J. Korean Med. Sci. 31(1), 47–54 (2016)CrossRef J.W. Lee, J. Lee, Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome. J. Korean Med. Sci. 31(1), 47–54 (2016)CrossRef
8.
go back to reference K. Ohkubo, T. Matsuzaki, M. Yuki, R. Yoshida, Y. Terawaki, A. Maeyama, H. Kawashima, J. Ono, T. Yanase, A. Matsunaga, A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration. Meta. Gene. 2, 342–348 (2014)CrossRef K. Ohkubo, T. Matsuzaki, M. Yuki, R. Yoshida, Y. Terawaki, A. Maeyama, H. Kawashima, J. Ono, T. Yanase, A. Matsunaga, A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration. Meta. Gene. 2, 342–348 (2014)CrossRef
9.
go back to reference Y. Han, Y. Lin, Q. Sun, S. Wang, Y. Gao, L. Shao, Mutation spectrum of Chinese patients with Bartter syndrome. Oncotarget 8(60), 101614–101622 (2017)CrossRef Y. Han, Y. Lin, Q. Sun, S. Wang, Y. Gao, L. Shao, Mutation spectrum of Chinese patients with Bartter syndrome. Oncotarget 8(60), 101614–101622 (2017)CrossRef
10.
go back to reference S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405–424 (2015)CrossRef S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405–424 (2015)CrossRef
11.
go back to reference M. Peters, S. Ermert, N. Jeck, C. Derst, U. Pechmann, S. Weber, K.P. Schlingmann, H.W. Seyberth, S. Waldegger, M. Konrad, Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 64(3), 923–932 (2003)CrossRef M. Peters, S. Ermert, N. Jeck, C. Derst, U. Pechmann, S. Weber, K.P. Schlingmann, H.W. Seyberth, S. Waldegger, M. Konrad, Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 64(3), 923–932 (2003)CrossRef
12.
go back to reference Y. Yu, C. Xu, X. Pan, H. Ren, W. Wang, X. Meng, F. Huang, N. Chen, Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome. Clin. Genet. 77(2), 155–162 (2010)CrossRef Y. Yu, C. Xu, X. Pan, H. Ren, W. Wang, X. Meng, F. Huang, N. Chen, Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome. Clin. Genet. 77(2), 155–162 (2010)CrossRef
13.
go back to reference O. Andrini, M. Keck, S. L’Hoste, R. Briones, L. Mansour-Hendili, T. Grand, F.V. Sepulveda, A. Blanchard, S. Lourdel, R. Vargas-Poussou, J. Teulon, CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels. Pflugers Arch. 466(9), 1713–1723 (2014)CrossRef O. Andrini, M. Keck, S. L’Hoste, R. Briones, L. Mansour-Hendili, T. Grand, F.V. Sepulveda, A. Blanchard, S. Lourdel, R. Vargas-Poussou, J. Teulon, CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels. Pflugers Arch. 466(9), 1713–1723 (2014)CrossRef
14.
go back to reference M. Keck, O. Andrini, O. Lahuna, J. Burgos, L.P. Cid, F.V. Sepulveda, S. L’Hoste, A. Blanchard, R. Vargas-Poussou, S. Lourdel, J. Teulon, Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression. Hum. Mutat. 34(9), 1269–1278 (2013)CrossRef M. Keck, O. Andrini, O. Lahuna, J. Burgos, L.P. Cid, F.V. Sepulveda, S. L’Hoste, A. Blanchard, R. Vargas-Poussou, S. Lourdel, J. Teulon, Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression. Hum. Mutat. 34(9), 1269–1278 (2013)CrossRef
15.
go back to reference S. Waldegger, T.J. Jentsch, Functional and structural analysis of ClC-K chloride channels involved in renal disease. J. Biol. Chem. 275(32), 24527–24533 (2000)CrossRef S. Waldegger, T.J. Jentsch, Functional and structural analysis of ClC-K chloride channels involved in renal disease. J. Biol. Chem. 275(32), 24527–24533 (2000)CrossRef
16.
go back to reference T.J. Jentsch, CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit. Rev. Biochem. Mol. Biol. 43(1), 3–36 (2008)CrossRef T.J. Jentsch, CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit. Rev. Biochem. Mol. Biol. 43(1), 3–36 (2008)CrossRef
17.
go back to reference D.B. Simon, R.S. Bindra, T.A. Mansfield, C. Nelson-Williams, E. Mendonca, R. Stone, S. Schurman, A. Nayir, H. Alpay, A. Bakkaloglu, J. Rodriguez-Soriano, J.M. Morales, S.A. Sanjad, C.M. Taylor, D. Pilz, A. Brem, H. Trachtman, W. Griswold, G.A. Richard, E. John, R.P. Lifton, Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat. Genet. 17(2), 171–178 (1997)CrossRef D.B. Simon, R.S. Bindra, T.A. Mansfield, C. Nelson-Williams, E. Mendonca, R. Stone, S. Schurman, A. Nayir, H. Alpay, A. Bakkaloglu, J. Rodriguez-Soriano, J.M. Morales, S.A. Sanjad, C.M. Taylor, D. Pilz, A. Brem, H. Trachtman, W. Griswold, G.A. Richard, E. John, R.P. Lifton, Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat. Genet. 17(2), 171–178 (1997)CrossRef
18.
go back to reference B.H. Lee, H.Y. Cho, H. Lee, K.H. Han, H.G. Kang, I.S. Ha, J.H. Lee, Y.S. Park, J.I. Shin, D.Y. Lee, S.Y. Kim, Y. Choi, H.I. Cheong, Genetic basis of Bartter syndrome in Korea. Nephrol. Dial. Transplant. 27(4), 1516–1521 (2012)CrossRef B.H. Lee, H.Y. Cho, H. Lee, K.H. Han, H.G. Kang, I.S. Ha, J.H. Lee, Y.S. Park, J.I. Shin, D.Y. Lee, S.Y. Kim, Y. Choi, H.I. Cheong, Genetic basis of Bartter syndrome in Korea. Nephrol. Dial. Transplant. 27(4), 1516–1521 (2012)CrossRef
19.
go back to reference D. Landau, E. Gurevich, L. Sinai-Treiman, H. Shalev, Accentuated hyperparathyroidism in type II Bartter syndrome. Pediatr. Nephrol. 31(7), 1085–1090 (2016)CrossRef D. Landau, E. Gurevich, L. Sinai-Treiman, H. Shalev, Accentuated hyperparathyroidism in type II Bartter syndrome. Pediatr. Nephrol. 31(7), 1085–1090 (2016)CrossRef
20.
go back to reference N. Jeck, M. Konrad, M. Peters, S. Weber, K.E. Bonzel, H.W. Seyberth, Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr. Res. 48(6), 754–758 (2000)CrossRef N. Jeck, M. Konrad, M. Peters, S. Weber, K.E. Bonzel, H.W. Seyberth, Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr. Res. 48(6), 754–758 (2000)CrossRef
21.
go back to reference S.C. Reinalter, N. Jeck, C. Brochhausen, B. Watzer, R.M. Nusing, H.W. Seyberth, M. Komhoff, Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 62(1), 253–260 (2002)CrossRef S.C. Reinalter, N. Jeck, C. Brochhausen, B. Watzer, R.M. Nusing, H.W. Seyberth, M. Komhoff, Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 62(1), 253–260 (2002)CrossRef
22.
go back to reference G. Gasongo, L.A. Greenbaum, O. Niel, T. Kwon, M.A. Macher, A. Maisin, V. Baudouin, C. Dossier, G. Deschenes, J. Hogan, Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome. Pediatr. Nephrol. 34(4), 679–684 (2019)CrossRef G. Gasongo, L.A. Greenbaum, O. Niel, T. Kwon, M.A. Macher, A. Maisin, V. Baudouin, C. Dossier, G. Deschenes, J. Hogan, Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome. Pediatr. Nephrol. 34(4), 679–684 (2019)CrossRef
23.
go back to reference Y. Han, X. Zhao, S. Wang, C. Wang, D. Tian, Y. Lang, I. Bottillo, X. Wang, L. Shao, Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I. Endocrine 64(3), 708–718 (2019)CrossRef Y. Han, X. Zhao, S. Wang, C. Wang, D. Tian, Y. Lang, I. Bottillo, X. Wang, L. Shao, Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I. Endocrine 64(3), 708–718 (2019)CrossRef
24.
go back to reference T. Liu, C. Wang, J. Lu, X. Zhao, Y. Lang, L. Shao, Genotype/phenotype analysis in 67 Chinese patients with Gitelman’s syndrome. Am. J. Nephrol. 44(2), 159–168 (2016)CrossRef T. Liu, C. Wang, J. Lu, X. Zhao, Y. Lang, L. Shao, Genotype/phenotype analysis in 67 Chinese patients with Gitelman’s syndrome. Am. J. Nephrol. 44(2), 159–168 (2016)CrossRef
25.
go back to reference R. Vargas-Poussou, K. Dahan, D. Kahila, A. Venisse, E. Riveira-Munoz, H. Debaix, B. Grisart, F. Bridoux, R. Unwin, B. Moulin, J.P. Haymann, M.C. Vantyghem, C. Rigothier, B. Dussol, M. Godin, H. Nivet, L. Dubourg, I. Tack, A.P. Gimenez-Roqueplo, P. Houillier, A. Blanchard, O. Devuyst, X. Jeunemaitre, Spectrum of mutations in Gitelman syndrome. J. Am. Soc. Nephrol. 22(4), 693–703 (2011)CrossRef R. Vargas-Poussou, K. Dahan, D. Kahila, A. Venisse, E. Riveira-Munoz, H. Debaix, B. Grisart, F. Bridoux, R. Unwin, B. Moulin, J.P. Haymann, M.C. Vantyghem, C. Rigothier, B. Dussol, M. Godin, H. Nivet, L. Dubourg, I. Tack, A.P. Gimenez-Roqueplo, P. Houillier, A. Blanchard, O. Devuyst, X. Jeunemaitre, Spectrum of mutations in Gitelman syndrome. J. Am. Soc. Nephrol. 22(4), 693–703 (2011)CrossRef
26.
go back to reference A. Bettinelli, N. Borsa, R. Bellantuono, M.L. Syren, R. Calabrese, A. Edefonti, J. Komninos, M. Santostefano, L. Beccaria, I. Pela, M.G. Bianchetti, S. Tedeschi, Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome. Am. J. Kidney Dis. 49(1), 91–98 (2007)CrossRef A. Bettinelli, N. Borsa, R. Bellantuono, M.L. Syren, R. Calabrese, A. Edefonti, J. Komninos, M. Santostefano, L. Beccaria, I. Pela, M.G. Bianchetti, S. Tedeschi, Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome. Am. J. Kidney Dis. 49(1), 91–98 (2007)CrossRef
27.
go back to reference G. Colussi, M.E. De Ferrari, S. Tedeschi, S. Prandoni, M.L. Syren, G. Civati, Bartter syndrome type 3: an unusual cause of nephrolithiasis. Nephrol. Dial. Transplant. 17(3), 521–523 (2002)CrossRef G. Colussi, M.E. De Ferrari, S. Tedeschi, S. Prandoni, M.L. Syren, G. Civati, Bartter syndrome type 3: an unusual cause of nephrolithiasis. Nephrol. Dial. Transplant. 17(3), 521–523 (2002)CrossRef
28.
go back to reference S. Fukuyama, M. Hiramatsu, M. Akagi, M. Higa, T. Ohta, Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria. J. Clin. Endocrinol. Metab. 89(11), 5847–5850 (2004)CrossRef S. Fukuyama, M. Hiramatsu, M. Akagi, M. Higa, T. Ohta, Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria. J. Clin. Endocrinol. Metab. 89(11), 5847–5850 (2004)CrossRef
29.
go back to reference X. Yang, G. Zhang, M. Wang, H. Yang, Q. Li, Bartter Syndrome type 3: phenotype-genotype correlation and favorable response to ibuprofen. Front Pediatr. 6, 153 (2018)CrossRef X. Yang, G. Zhang, M. Wang, H. Yang, Q. Li, Bartter Syndrome type 3: phenotype-genotype correlation and favorable response to ibuprofen. Front Pediatr. 6, 153 (2018)CrossRef
Metadata
Title
Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3
Authors
Yue Han
Hai Cheng
Shihong Shao
Yanhua Lang
Xiangzhong Zhao
Yi Lin
Sai Wang
Xiaomeng Shi
Zhiying Liu
Leping Shao
Publication date
01-04-2020
Publisher
Springer US
Keyword
Hypokalemia
Published in
Endocrine / Issue 1/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02156-9

Other articles of this Issue 1/2020

Endocrine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.